Pyxis Oncology Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
28 Sep 23 | BuyUS$14,960 | Pamela Connealy | Individual | 8,000 | US$1.87 | |
27 Sep 23 | BuyUS$11,868 | Pamela Connealy | Individual | 6,426 | US$1.85 | |
27 Sep 23 | BuyUS$4,675 | Jitendra Wadhane | Individual | 2,500 | US$1.87 | |
25 Sep 23 | BuyUS$20,044 | Pamela Connealy | Individual | 12,000 | US$1.67 | |
25 Sep 23 | BuyUS$8,850 | Jitendra Wadhane | Individual | 5,000 | US$1.77 | |
22 Sep 23 | BuyUS$8,695 | Pamela Connealy | Individual | 5,000 | US$1.74 | |
22 Sep 23 | BuyUS$4,349 | Jitendra Wadhane | Individual | 2,500 | US$1.74 | |
18 Sep 23 | SellUS$18,161 | Lara Sullivan | Individual | 8,641 | US$2.25 | |
13 Sep 23 | SellUS$63,301 | Lara Sullivan | Individual | 27,917 | US$2.27 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 5,639 | 0.00958% |
Hedge Funds | 3,170,803 | 5.39% |
VC/PE Firms | 4,184,100 | 7.11% |
Individual Insiders | 6,672,329 | 11.3% |
Public Companies | 8,694,601 | 14.8% |
Institutions | 12,981,971 | 22% |
General Public | 23,166,947 | 39.3% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 55.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
5,956,443 | US$26.1m | 0% | 48.04% | |||
5,952,263 | US$26.1m | 0% | no data | |||
4,952,364 | US$21.7m | 316% | no data | |||
4,184,100 | US$18.3m | 0% | 0.6% | |||
3,170,803 | US$13.9m | 0% | 0.5% | |||
2,742,338 | US$12.0m | 0% | no data | |||
1,306,685 | US$5.7m | 14.6% | no data | |||
1,080,507 | US$4.7m | 0% | 99.33% | |||
708,303 | US$3.1m | 0% | no data | |||
624,231 | US$2.7m | 9.17% | no data | |||
440,000 | US$1.9m | 0% | 0.21% | |||
382,606 | US$1.7m | 0% | 0.01% | |||
377,796 | US$1.7m | 58.4% | no data | |||
364,150 | US$1.6m | 68.4% | no data | |||
326,810 | US$1.4m | 0% | 0.16% | |||
310,598 | US$1.4m | 3.01% | no data | |||
308,241 | US$1.4m | 6.92% | no data | |||
236,195 | US$1.0m | 0% | 0.02% | |||
216,186 | US$946.9k | 181% | no data | |||
206,186 | US$903.1k | 209% | no data | |||
162,108 | US$710.0k | 905% | no data | |||
154,971 | US$678.8k | 10.5% | no data | |||
125,000 | US$547.5k | 0% | no data | |||
125,000 | US$547.5k | 0% | no data | |||
111,937 | US$490.3k | -1.72% | 0.21% |